πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,301 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7473780

Drying process for preparing crystalline solid famciclovir

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Jan 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7468444

Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Dec 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7465466

Compositions and methods for prostate and kidney health and disorders, an herbal preparati

Integrated Chinese Medicine Holdings Ltd. Β· Granted Tue Dec 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7465715

Method for treatment of multiple sclerosis

CAN-FITE BIOPHARMA LTD. Β· Granted Tue Dec 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7462737

Pregabalin free of isobutylglutaric acid and a process for preparation thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Dec 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7456297

Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Nov 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7449202

Compositions and methods for prostate and kidney health and disorders, an herbal preparati

Integrated Chinese Medicine Holdings Ltd. Β· Granted Tue Nov 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7442806

Processes for preparing darifenacin hydrobromide

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Oct 28 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 23 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7439013

Biocompatible polymer and filter for selectively eliminating leucocytes using the same

ASAHI KASEI KURARAY MEDICAL CO., LTD. Β· Granted Tue Oct 21 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7435741

2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butan

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Oct 14 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 09 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7429374

Process for the measurement of the potency of glatiramer acetate

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Sep 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7420084

Polymorphic forms of nateglinide

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7417165

Crystalline forms of pregabalin

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Aug 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7417044

Tadalafil having a large particle size and a process for preparation thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Aug 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7414140

Fluvastatin sodium crystal forms, processes for preparing them, compositions containing th

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Aug 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7411067

Crystalline forms of gatifloxacin

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7410363

Electrical connector having compliant biasing device

Hon Hai Precision Ind. Co., Ltd. Β· Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7407939

Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or peptidomimetic

CureGenics Ltd. Β· Granted Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7396860

Use of rasagiline with or without riluzole to treat amyotrophic lateral sclerosis

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Jul 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7396927

Process for preparation of rosuvastatin calcium

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Jul 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7396542

Stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Jul 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7390807

Crystal forms of lamotrigine and processes for their preparations

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Jun 24 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 19 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7375074

Body weight gain inhibitor

Takeda Chemical Industries Ltd. Β· Granted Tue May 20 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7368606

Amorphous cinacalcet hydrochloride and preparation thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted